🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
RATIONALE: Antiemetic drugs, such as aprepitant and ondansetron, may help l...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00499668
Treatments Being Tested
RATIONALE: Giving an infusion of natural killer cells from a donor after a ...
Status
Completed
Location
University of Ulsan, Asan Medical Center
Start Date
2009-01
Trial ID
NCT00823524
Treatments Being Tested
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidi...
Status
Active Not Recruiting
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2009-09
Trial ID
NCT00935090
Treatments Being Tested
To expresse TIGIT in NK Cells in Patients with Chronic Myeloid Leukemia...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04818619
Treatments Being Tested
RATIONALE: Collecting and storing samples of bone marrow and blood from pat...
Status
Terminated
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2008-04
Trial ID
NCT00918658
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as talotrexin, work in differen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00458744
Treatments Being Tested
RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and tota...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2006-02
Trial ID
NCT00354172
This phase I/II studies the side effects and best dose of natural killer ce...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2014-04-22
Trial ID
NCT01904136
RATIONALE: Giving chemotherapy, such as fludarabine, busulfan, and melphala...
Status
Completed
Location
Wake Forest University Comprehensive Cancer Center
Start Date
2007-02
Trial ID
NCT00453206